Shanghai Shen Lian Biomedical Corporation was established in 2001. It is a high-tech enterprise, professional engaged in the R&D, production and sales of veterinary biological products. The main products are swine foot-and-mouth disease vaccine. Shen Lian Biomedical is China's first synthetic peptide vaccine manufacturer. The sales of the company's products rank first for more than ten years in the domestic market of synthetic peptide vaccine for foot-and-mouth disease.
While consolidating the advantage of the synthetic peptide vaccine for foot-and-mouth disease, the company is actively engaged in the R&D of the inactivated vaccine for foot-and-mouth disease. In 2017, the first domestic and foreign divalent inactivated vaccine for swine foot-and-mouth disease with type O and type A was successfully developed which obtained the national class-one new veterinary drug registration certificate. It enriched the company's product structure to enhance the company's market competitiveness.
After continuous research and development innovation，the company has get numerous R&D results and honors，including one National Grade II Prize of Science and Technology Progress and five New Veterinary Drug Registration Certificate and two of them are National Class-one.
|Full name||Shanghai Shen Lian Biomedical Corporation|
|Abbreviations||Shen Lian Biomedical|
|Has weighted voting rights structure?||No|
|Earnings Per Share||0.26||0.30||0.23|
|R&D expenditure as a % of operating revenue||7.74%||5.51%||6.26%|
|Total Owners' Equity||832||549||465|
|Net Cash Flows-Operating||121||75||48|
|Net Cash Flows-Investing||-77||-103||-77|
|Net Cash Flows-Financing||196||12||29|
|Name||No. of Shares Held (mn)||% of Shares Held|
|UNITED BIOMEDICAL INC||68.23||18.97%|
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.